Skip to content
FIND A HEALTH VALLEY ACTOR

Bio Asia-Taiwan

Bio Asia Taiwan

BIO Asia–Taiwan 2025 will be held from 16 to 19 July 2026 in Tapei, Taiwan   The event brings together bioindustry executives and investors from North America, Europe and Asia to explore business opportunities and to engage with Taiwan’s emerging biotech sector. The five-day gathering includes a three-day conference featuring internationally-renowned speakers, company presentations from…

Read More

11 Swiss Life Sciences projects selected by MassChallenge

MassChallenge

MassChallenge Switzerland, part of the global MassChallenge network, announced the 103 early-stage startups selected for the 2025 accelerator programme. 11 Swiss Life Sciences projects are in the list.   Healthtech Actival (Switzerland): Actival has a patented approach of directly manufacturing clear dental aligners with integrated microfluidic channels. These microfluidic channels act as reservoirs that slowly release beneficial antibacterial…

Read More

BIOKET

BIOKET

BIOKET is taking place from 17 to 19 March in Fribourg BIOKET is an annual international Conference that serves as a premier platform dedicated to advancing Key Enabling Technologies and innovations applied to biomass valorization. The conference aims to promote the production of high added value products across diverse sectors of the economy through sustainable…

Read More

Swiss Health Valley Startups Shine at Major Pitching Events

Swiss Health Valley Startups Light

The Swiss Health Valley continues to be a powerhouse of innovation, as multiple startups made their mark at major pitching events across Europe. These groundbreaking companies are not only transforming health and wellness but also bringing international recognition to the region.     At Start Contest 2024-2025, PMAX Labs emerged as the grand prize winner…

Read More

Innobooster Gebert Rüf Stiftung

GebertRuefStiftung_Innobooster

Apply before 1 February 2026 for the Gebert Rüf Stiftung Innobooster and get up to a CHF 150,000 support Gebert Rüf Stiftungsupports university-based, high-potential businesses from the Venture Kick program with the aim of substantially accelerating their market entry. The funding line is calling for top talents with convincing proposals of how a research &…

Read More

Syrhatech Completes A CHF 4.5 Million Financing Round

Syrhatech

Syrhatech, a French-Swiss CDMO innovating in the development and manufacture of injectable medical devices based in particular on hyaluronic acid, announces the closing of an investment of CHF 4.5 million, completed with strategic investors.   Funding for innovation and industrial capacity This investment will enable Syrhatech to strengthen its R&D team at its site in Geneva, and to deploy a…

Read More

PANORAMAI

Panoramai

Panoramai is taking place from 3 to 5 June 2025 at Campus Unlimitrust in Renens   Within the Gen AI ecosystem, discover real-life use cases and AI-powered digital transformation stories with entrepreneurs and business experts. The event also aims to enrich the horizons and potential applications of AI by exploring creative perspectives on uses and…

Read More

NewBiologix Licences Xcell-Eng-HEK293 Cell Line to Recipharm

NewBiologix Recipharm

NewBiologix, a Biopôle-based (Vaud)Swiss biotech innovator, has granted a non-exclusive licence to Recipharm Advanced Bio.   The agreement gives Recipharm access to NewBiologix’s Xcell-Eng-HEK293 cell lines, enabling the efficient production of recombinant Adeno-Associated Viruses (rAAVs) for cell and gene therapies. The licensed cell lines offer high-yield, GMP-ready viral production, accelerating the path to clinical trials.…

Read More

Hedera Dx Secures €15 Million Series A

Hedera DX

Hedera Dx Raises €15M Series A to Expand Access to Precision Oncology Across Europe   Hedera Dx, a Vaud-Based techbio company advancing precision cancer care, announced the successful close of a €15 million Series A financing round. The round was led by Vsquared Ventures, with new investor Tesi joining and strong support from existing backers…

Read More

Timeline® Named Milestone 1 Award Winner in XPRIZE Healthspan Competition

Timeline

Timeline®, a leading longevity biotech company (parent company Amazentis in Canton of Vaud) and maker of Mitopure®, has been named a Milestone 1 Award Winner in the prestigious XPRIZE Healthspan competition. Selected from hundreds of global entrants, Timeline is among the Top 40 international teams recognized for advancing innovative, safe, and science-backed solutions to extend…

Read More